Company: SNSE
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0000950170-25-103101
Chunk: 3

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Item 1A
Chunk 3
---
 trials for our product candidates. If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.

•Clinical trials are difficult to design and implement, can be lengthy and expensive, involve uncertain outcomes and may not ultimately be successful.

•Risks Related to our Dependence on Third Parties

•We collaborate with third parties in connection with the development of our product candidates, and may depend upon future collaboration partners to commit to the research, development, manufacturing and marketing of our product candidates.

•We rely, and expect to continue to rely, on third parties to conduct the preclinical and clinical trials for our product candidates, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials or failing to comply with applicable regulatory requirements.